Sublingual Semaglutide Compounds — Dosing, Clinical Application & Regulatory...
PCCA Products
•
1h 5m
Download Handouts: https://bit.ly/41Jsswf
When considering the sublingual route of administration for semaglutide, it is important to understand the available science, plus clinical and legal considerations. Join us for this free, non-CE webinar to stay informed and provide enhanced care.
What you'll learn:
Practical Insights: PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh, will discuss dosing considerations, safety information including potential side effects, advantages and challenges of sublingual administration, and transitioning from other dosage forms to sublingual administration.
Microdosing Considerations: PCCA Clinical Compounding Pharmacist Catherine Henderson, PharmD, will provide a comprehensive understanding of GLP-1, clinical applications, and the potential benefits and challenges of microdosing.
Regulatory Updates: PCCA Vice President of Clinical Services Matt Martin, PharmD, BCSCP, will address the current legal and regulatory landscape surrounding compounding GLP-1 medications.
Don’t miss this opportunity to deepen your understanding and improve patient outcomes.
Speakers:
Sebastian Denison, RPh
Catherine Henderson, PharmD
Matt Martin, PharmD, BCSCP
Up Next in PCCA Products
-
Low-dose Naltrexone: What's New
Join us to discover the latest and greatest in naltrexone compounding with PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh. He'll share updated information you need to know, plus uncover new compounding options to grow your practice.
You'll learn:
New and updated LDN dosing consider...
-
Data and Dosing on Sublingual Deliver...
Download Handouts: https://bit.ly/48Q3kWG
Are you curious about the latest advancements in the sublingual delivery of semaglutide? Join us for an insightful and informative FREE webinar led by PCCA Chief Scientific Officer Gus Bassani, PharmD, PCCA Director of Research & Development Daniel Banov...
-
Solving the Most Common USP 795 Imple...
For pharmacies performing nonsterile compounding, USP 795 is no longer optional. In many states, it’s now mandatory; and where it isn’t yet, it remains the best practice standard for compounding in a way that best protects patient and compounder safety.
Tackle the biggest and easiest-to-miss cha...
